ESALF
Price
$32.32
Change
+$0.02 (+0.06%)
Updated
Sep 5 closing price
Capitalization
9.77B
HLTRF
Price
$3.80
Change
-$0.00 (-0.00%)
Updated
Aug 27 closing price
Capitalization
123.84M
Interact to see
Advertisement

ESALF vs HLTRF

Header iconESALF vs HLTRF Comparison
Open Charts ESALF vs HLTRFBanner chart's image
Eisai
Price$32.32
Change+$0.02 (+0.06%)
Volume$250
Capitalization9.77B
HLS Therapeutics
Price$3.80
Change-$0.00 (-0.00%)
Volume$100
Capitalization123.84M
ESALF vs HLTRF Comparison Chart in %
Loading...
ESALF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ESALF vs. HLTRF commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESALF is a StrongBuy and HLTRF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (ESALF: $32.32 vs. HLTRF: $3.80)
Brand notoriety: ESALF and HLTRF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ESALF: 9% vs. HLTRF: 3%
Market capitalization -- ESALF: $9.77B vs. HLTRF: $123.84M
ESALF [@Pharmaceuticals: Generic] is valued at $9.77B. HLTRF’s [@Pharmaceuticals: Generic] market capitalization is $123.84M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESALF’s FA Score shows that 2 FA rating(s) are green whileHLTRF’s FA Score has 1 green FA rating(s).

  • ESALF’s FA Score: 2 green, 3 red.
  • HLTRF’s FA Score: 1 green, 4 red.
According to our system of comparison, ESALF is a better buy in the long-term than HLTRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESALF’s TA Score shows that 7 TA indicator(s) are bullish while HLTRF’s TA Score has 3 bullish TA indicator(s).

  • ESALF’s TA Score: 7 bullish, 2 bearish.
  • HLTRF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ESALF is a better buy in the short-term than HLTRF.

Price Growth

ESALF (@Pharmaceuticals: Generic) experienced а +13.40% price change this week, while HLTRF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESALF($9.77B) has a higher market cap than HLTRF($124M). HLTRF YTD gains are higher at: 41.264 vs. ESALF (25.808). ESALF has higher annual earnings (EBITDA): 101B vs. HLTRF (15.5M). ESALF has more cash in the bank: 269B vs. HLTRF (12.2M). HLTRF has less debt than ESALF: HLTRF (55.6M) vs ESALF (183B). ESALF has higher revenues than HLTRF: ESALF (753B) vs HLTRF (56.4M).
ESALFHLTRFESALF / HLTRF
Capitalization9.77B124M7,877%
EBITDA101B15.5M651,613%
Gain YTD25.80841.26463%
P/E Ratio29.21N/A-
Revenue753B56.4M1,335,106%
Total Cash269B12.2M2,204,918%
Total Debt183B55.6M329,137%
FUNDAMENTALS RATINGS
ESALF vs HLTRF: Fundamental Ratings
ESALF
HLTRF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
26
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
696
PRICE GROWTH RATING
1..100
4844
P/E GROWTH RATING
1..100
91100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ESALF's Valuation (11) in the null industry is in the same range as HLTRF (26). This means that ESALF’s stock grew similarly to HLTRF’s over the last 12 months.

ESALF's Profit vs Risk Rating (100) in the null industry is in the same range as HLTRF (100). This means that ESALF’s stock grew similarly to HLTRF’s over the last 12 months.

ESALF's SMR Rating (6) in the null industry is significantly better than the same rating for HLTRF (96). This means that ESALF’s stock grew significantly faster than HLTRF’s over the last 12 months.

HLTRF's Price Growth Rating (44) in the null industry is in the same range as ESALF (48). This means that HLTRF’s stock grew similarly to ESALF’s over the last 12 months.

ESALF's P/E Growth Rating (91) in the null industry is in the same range as HLTRF (100). This means that ESALF’s stock grew similarly to HLTRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ESALFHLTRF
RSI
ODDS (%)
Bearish Trend 3 days ago
54%
Bearish Trend 3 days ago
52%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
36%
Bearish Trend 4 days ago
57%
Momentum
ODDS (%)
Bullish Trend 3 days ago
44%
Bullish Trend 4 days ago
40%
MACD
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
53%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
37%
Bullish Trend 3 days ago
50%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
45%
Bullish Trend 3 days ago
47%
Advances
ODDS (%)
N/A
Bullish Trend 21 days ago
50%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
49%
Bearish Trend 3 days ago
57%
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
50%
View a ticker or compare two or three
Interact to see
Advertisement
ESALF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGPSX80.250.45
+0.56%
ProFunds Mid Cap Growth Svc
FRINX12.22N/A
N/A
Fidelity Advisor Real Estate Income A
GMOWX20.01N/A
N/A
GMO Resources VI
PGIUX15.64N/A
N/A
Virtus Duff & Phelps Global Infras I
FIVCX36.91-0.01
-0.03%
Macquarie Opportunity C

ESALF and

Correlation & Price change

A.I.dvisor tells us that ESALF and ESAIY have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESALF and ESAIY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESALF
1D Price
Change %
ESALF100%
+0.06%
ESAIY - ESALF
30%
Poorly correlated
+2.66%
KHTRF - ESALF
27%
Poorly correlated
N/A
DVAX - ESALF
22%
Poorly correlated
+0.80%
BLMH - ESALF
20%
Poorly correlated
-1.59%
DBCCF - ESALF
15%
Poorly correlated
-3.24%
More

HLTRF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLTRF has been loosely correlated with PHCUF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if HLTRF jumps, then PHCUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLTRF
1D Price
Change %
HLTRF100%
N/A
PHCUF - HLTRF
38%
Loosely correlated
N/A
INCR - HLTRF
21%
Poorly correlated
+0.27%
GTBIF - HLTRF
3%
Poorly correlated
+4.55%
ESALF - HLTRF
3%
Poorly correlated
+0.06%
INDV - HLTRF
2%
Poorly correlated
+1.01%
More